Last week’s news that MD Anderson Cancer Center has pulled the plug on its two year partnership with IBM-Watson led many critics to wonder out loud if the machine-learning revolution is in trouble, and if Big Data could be about to become the latest tech industry buzzword to die a well-deserved death. It’s a little more complicated than that, argues HealthCatalyst’s Dale Sanders in this can’t-miss presentation. The problems with the MD Anderson-Watson partnership probably say more about the “Big Data Industry” and the goings-on at IBM as they do about the technology. Still, there are important lessons we can learn from the episode.
- “Big Data Bust: MD Anderson IBM Watson Project Dies” (Medscape, Feb 22)
- “MD Anderson Benches IBM Watson in Setback For Artificial Intelligence”
(Forbes, Feb 19) - “As Rometty Prepares to Open HIMSS, MD Anderson Walks Away…”
(MedCity News, Feb 19″) - “Watson Can’t Cure Cancer .. or the Stuff That Breaks IT Projects” (The Register, Feb 20)
Categories: Uncategorized
